Cargando…
Targeting dormant phenotype acquired mycobacteria using natural products by exploring its important targets: In vitro and in silico studies
The dormant phenotype of Mycobacterium tuberculosis that develops during infection poses a major challenge in disease treatment, since these bacilli show tolerance to front-line drugs. An in vitro hypoxia dormancy model was established, which produced phenotypically dormant Mycobacterium smegmatis a...
Autores principales: | Sharma, Shweta, Chikhale, Rupesh, Shinde, Nivedita, Khan, A. M., Gupta, Vivek Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080046/ https://www.ncbi.nlm.nih.gov/pubmed/37033483 http://dx.doi.org/10.3389/fcimb.2023.1111997 |
Ejemplares similares
-
Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
por: Verma, Akanksha, et al.
Publicado: (2022) -
The Use of AlphaFold for In Silico Exploration of Drug Targets in the Parasite Trypanosoma cruzi
por: Ros-Lucas, Albert, et al.
Publicado: (2022) -
Comprehensive Determination of Mycobacterium tuberculosis and Nontuberculous Mycobacteria From Targeted Capture Sequencing
por: He, Ya, et al.
Publicado: (2020) -
Cell Surface Biosynthesis and Remodeling Pathways in Mycobacteria Reveal New Drug Targets
por: Shaku, Moagi, et al.
Publicado: (2020) -
Resuscitation of Dormant “Non-culturable” Mycobacterium tuberculosis Is Characterized by Immediate Transcriptional Burst
por: Salina, Elena G., et al.
Publicado: (2019)